Covered recipient · General Payments record
JESSICA SHDO
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$8,865.67
- Reported across 100 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $705.05 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $601.68 | 13 |
| Galderma Laboratories, L.P. | $74.97 | 4 |
| MERZ NORTH AMERICA, INC. | $28.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.18 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108183815 | CMS |
| ABBVIE INC. | $4.95 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108183817 | CMS |
| ABBVIE INC. | $23.87 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108183819 | CMS |
| ABBVIE INC. | $18.96 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108183821 | CMS |
| ABBVIE INC. | $26.53 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108183823 | CMS |
| ABBVIE INC. | $24.96 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108183825 | CMS |
| ABBVIE INC. | $24.37 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108183827 | CMS |
| ABBVIE INC. | $16.53 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108183829 | CMS |
| ABBVIE INC. | $32.44 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108183831 | CMS |
| ABBVIE INC. | $213.68 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108183833 | CMS |
| ABBVIE INC. | $26.49 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108183835 | CMS |
| ABBVIE INC. | $17.99 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108183837 | CMS |
| ABBVIE INC. | $145.73 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108183839 | CMS |
| Galderma Laboratories, L.P. | $17.94 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145391855 | CMS |
| Galderma Laboratories, L.P. | $19.57 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145391857 | CMS |
| Galderma Laboratories, L.P. | $21.66 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145391859 | CMS |
| Galderma Laboratories, L.P. | $15.80 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145391861 | CMS |
| MERZ NORTH AMERICA, INC. | $28.40 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146385117 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.